Etanercept decreases the innate immune wounding response in psoriasis.


Cathelicidin is increased when normal skin is injured and in psoriasis lesions where it has been suggested to play a pivotal role in inflammation through interactions with self-DNA and toll-like receptor 9 (TLR-9) in keratinocytes and plasmacytoid dendritic cells. Because of etanercept's success in treating psoriasis, we hypothesized that etanercept may… (More)
DOI: 10.1111/exd.12167


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics